secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2024-01-02T23:59:59+00:00
Accession:  0001104659-24-000325
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical secures up to $20M credit facility from SWK Holdings for DFD-29 launch and general purposes
--------------------------------------------------------------------------------

- Entered into credit facility with SWK Funding LLC for up to $20M; initial draw of $15M on Dec 27, 2023.
- Additional $5M available within 12 months subject to operational and financial milestones.
- Term loan matures Dec 27, 2027; interest rate = 3-month SOFR (floor 5%) + 7.75%, quarterly payments.
- Funds to support general corporate purposes and DFD-29 NDA submission and potential commercial launch.
- Prepayment premium: 2% if within 1 year, 1% if between 1-2 years, 0% thereafter; exit fee of 5% of original principal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924000325/0001104659-24-000325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924000325/tm2333941d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-000325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer